SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
申请人:INCYTE CORPORATION
公开号:US20130338134A1
公开(公告)日:2013-12-19
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Substituted tricyclic compounds as FGFR inhibitors
申请人:Incyte Corporation
公开号:US11053246B2
公开(公告)日:2021-07-06
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.